World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
14061
World Ranking
3690
National Ranking
37

Overview

Reinhard Kirnbauer is affiliated with the Medical University of Vienna in Austria. Their research primarily focuses on medicine, with significant contributions in immunology and microbiology, as well as biochemistry, genetics, and molecular biology. Their work spans several subfields including epidemiology, immunology, molecular biology, surgery, and cancer research.

The main topics addressed by Kirnbauer include cervical cancer and HPV research, immunotherapy and immune responses, immune response and inflammation, virus-based gene therapy research, herpesvirus infections and treatments, RNA interference and gene delivery, and colorectal and anal carcinomas.

The scientist has published in a range of scientific journals, notably the following venues:

  • Vaccine
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Cancer Discovery
  • Journal of Clinical Medicine
  • Journal of Virology

Some recent papers authored or co-authored by Kirnbauer include:

  • RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates (2021, Journal of Clinical Medicine)
  • Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers (2022, Cancer Discovery)
  • Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists (2020, Vaccine)
  • RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer (2022, Journal of Virology)
  • Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development (2022, Frontiers in Immunology)

Frequent co-authors collaborating with Kirnbauer include:

  • Richard B.S. Roden
  • Bettina Huber
  • Lígia A. Pinto
  • Robert H. Shoemaker
  • Jason D. Marshall

Best Publications

  • Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

    R Kirnbauer;F Booy;N Cheng;D R Lowy

  • Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

    A Köck;T Schwarz;R Kirnbauer;A Urbanski

  • Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

    Reinhard Kirnbauer;Janet Taub;Heather Greenstone;Richard Roden

  • Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

    F Breitburd;R Kirnbauer;N L Hubbert;B Nonnenmacher

  • Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

    Heather L. Greenstone;John D. Nieland;Karin E. de Visser;Marloes L. H. De Bruijn

  • A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

    Reinhard Kirnbauer;Nancy L. Hubbert;Cosette M. Wheeler;Thomas M. Becker

  • Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization

    R. Kirnbauer;L.M. Chandrachud;B.W. O'neil;E.R. Wagner

  • In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

    Richard B.S. Roden;Heather L. Greenstone;Reinhard Kirnbauer;Frank P. Booy

  • Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

    Saeed Shafti-Keramat;Alessandra Handisurya;Ernst Kriehuber;Guerrino Meneguzzi

  • Ultraviolet light induces increased circulating interleukin-6 in humans.

    Agatha Urbanski;Thomas Schwarz;Peter Neuner;Jean Krutmann

  • IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

    R Kirnbauer;A Köck;T Schwarz;A Urbanski

  • Genital human papillomavirus infection

    Douglas R. Lowy;Reinhard Kirnbauer;John T. Schiller

  • Cutaneous Human Papillomaviruses Found in Sun-Exposed Skin: Beta-papillomavirus Species 2 Predominates in Squamous Cell Carcinoma

    Ola Forslund;Thomas Iftner;Kristin Andersson;Bernt Lindelöf

  • Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids

    Reinhard Kirnbauer;Andreas Köck;Peter Neuner;Elisabeth Förster

  • Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

    R. B. S. Roden;E. M. Weissinger;D. W. Henderson;F. Booy

  • Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.

    Richard B.S. Roden;Nancy L. Hubbert;Reinhard Kirnbauer;Neil D. Christensen

  • Increased IL-6 Production by Monocytes and Keratinocytes in Patients with Psoriasis

    Peter Neuner;Agatha Urbanski;Franz Trautinger;Annelie Möller

  • Interaction of papillomaviruses with the cell surface.

    R. B. S. Roden;R. Kirnbauer;A. B. Jenson;D. R. Lowy

  • Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

    Matti Lehtinen;Joakim Dillner;Paul Knekt;Tapio Luostarinen

  • High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors.

    Ola Forslund;Bernt Lindelöf;Eva Hradil;Peter Nordin

Frequent Co-Authors

Richard B.S. Roden
Richard B.S. Roden Johns Hopkins University
John T. Schiller
John T. Schiller National Institutes of Health
Thomas Schwarz
Thomas Schwarz Boston Children's Hospital
Douglas R. Lowy
Douglas R. Lowy National Institutes of Health
Matti Lehtinen
Matti Lehtinen Tampere University
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Georg Stingl
Georg Stingl Medical University of Vienna
Neil D. Christensen
Neil D. Christensen Pennsylvania State University
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
Jean Krutmann
Jean Krutmann Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, branching into healthcare roles such as nurse practitioner specialties can be an excellent way to apply your knowledge in clinical settings. Exploring online pmhnp programs with clinical placement highlights the importance of hands-on training, which is crucial for advancing patient care skills alongside theoretical learning.

Cost is often a deciding factor when choosing a program. Many prospective students look for the cheapest online pmhnp programs to balance education quality with financial feasibility. Affordable options make advanced nursing degrees more accessible, promoting career growth in specialized fields.

Understanding earning potential is also key. The how much does a dnp make resource offers insight into salary expectations by state, helping students make informed decisions about where to study and eventually practice.

For those already in nursing, transitioning roles can expand career prospects. The guide on acute care nurse practitioner programs is valuable for nurses aiming to shift into more specialized, acute care settings, which often require advanced immunology knowledge.

Best Scientists Citing Reinhard Kirnbauer

Trending Scientists

Recently Published Articles